Using Kaplan-Meier survival analyses, it has been found that no statistically significant relationship between OS, post-progression survival and distant-metastasis-free survival rates and tumour cell-derived IDO1 expression exists in patients with various types of cancers, such as lung, ovarian, breast or gastric cancer[88]. This evidence concerns the gene IDO1 and gastric cancer.